News In Brief
This article was originally published in The Gray Sheet
Executive SummaryUtah Medical buys Femcare
You may also be interested in...
Final PMA approval for the artificial cervical disc implant remains subject to FDA review of labeling and quality system requirements.
Osprey Medical plans IPO. ViewRay raises $45 million. More financings.
Long-term positive outcomes for artificial cervical discs were reported, but the market remains muted by insurance restrictions, and even more data may be needed for a breakthrough.